Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2876)
All Articles published online
|
Nov 7, 2009 (publication date) through Jun 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kitade M, Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Yamazaki M, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Sawai M, Yoshida M, Morioka C, Tsujimoto T, Kawaratani H, Fukui H. Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis. World J Gastroenterol 2009; 15(41): 5193-5199 [PMID: 19891019 DOI: 10.3748/wjg.15.5193] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i41/5193.htm |
| Number | Citing Articles |
| 1 |
Yosuke Aihara, Hitoshi Yoshiji, Ryuichi Noguchi, Kosuke Kaji, Tadashi Namisaki, Yusaku Shirai, Akitoshi Douhara, Kei Moriya, Hideto Kawaratani, Hiroshi Fukui. Direct renin inhibitor, aliskiren, attenuates the progression of non‐alcoholic steatohepatitis in the rat model. Hepatology Research 2013; 43(11): 1241 doi: 10.1111/hepr.12081
|
| 2 |
Adel Hammoutene, Louise Biquard, Juliette Lasselin, Marouane Kheloufi, Marion Tanguy, Anne-Clémence Vion, Jules Mérian, Nathalie Colnot, Xavier Loyer, Alain Tedgui, Patrice Codogno, Sophie Lotersztajn, Valérie Paradis, Chantal M. Boulanger, Pierre-Emmanuel Rautou. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis. Journal of Hepatology 2020; 72(3): 528 doi: 10.1016/j.jhep.2019.10.028
|
| 3 |
David Højland Ipsen, Pernille Tveden-Nyborg. Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact. Biomedicines 2021; 9(1): 93 doi: 10.3390/biomedicines9010093
|
| 4 |
Davide Povero, Akiko Eguchi, Hongying Li, Casey D. Johnson, Bettina G. Papouchado, Alexander Wree, Karen Messer, Ariel E. Feldstein, Silvia C. Sookoian. Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease. PLoS ONE 2014; 9(12): e113651 doi: 10.1371/journal.pone.0113651
|
| 5 |
Anna Kakehashi, Vasily Stefanov, Naomi Ishii, Takahiro Okuno, Hideki Fujii, Kazuaki Kawai, Norifumi Kawada, Hideki Wanibuchi. Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas. International Journal of Molecular Sciences 2017; 18(2): 434 doi: 10.3390/ijms18020434
|
| 6 |
Stephanie Coulon, Vanessa Legry, Femke Heindryckx, Christophe Van Steenkiste, Christophe Casteleyn, Kim Olievier, Louis Libbrecht, Peter Carmeliet, Bart Jonckx, Jean-Marie Stassen, Hans Van Vlierberghe, Isabelle Leclercq, Isabelle Colle, Anja Geerts. Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. Hepatology 2013; 57(5): 1793 doi: 10.1002/hep.26219
|
| 7 |
Stergios A. Polyzos, Konstantinos A. Toulis, Dimitrios G. Goulis, Christos Zavos, Jannis Kountouras. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism 2011; 60(3): 313 doi: 10.1016/j.metabol.2010.09.003
|
| 8 |
Iulia Minciuna, Madalina Gabriela Taru, Bogdan Procopet, Horia Stefanescu. The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Medicine 2024; 13(5): 1406 doi: 10.3390/jcm13051406
|
| 9 |
Laure Elkrief, Pierre‐Emmanuel Rautou, Shiv Sarin, Dominique Valla, Valérie Paradis, Richard Moreau. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver International 2016; 36(7): 936 doi: 10.1111/liv.13115
|
| 10 |
Patrick Hamid Alizai, Lea Bertram, Daniela Kroy, Julia Kummer, Anne Andert, Ulf Peter Neumann, Tom Florian Ulmer, Athanassious Fragoulis. Expression of VEGFR-2 during Liver Regeneration after Partial Hepatectomy in a Bioluminescence Mouse Model. European Surgical Research 2017; 58(5-6): 330 doi: 10.1159/000479628
|
| 11 |
Amal Essaouiba, Teru Okitsu, Rie Kinoshita, Rachid Jellali, Marie Shinohara, Mathieu Danoy, Cécile Legallais, Yasuyuki Sakai, Eric Leclerc. Development of a pancreas-liver organ-on-chip coculture model for organ-to-organ interaction studies. Biochemical Engineering Journal 2020; 164: 107783 doi: 10.1016/j.bej.2020.107783
|
| 12 |
Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Kosuke Takeda, Kosuke Kaji, Yasushi Okura, Naotaka Shimozato, Shinya Sato, Norihisa Nishimura, Kenichiro Seki, Hideto Kawaratani, Hiroaki Takaya, Yasuhiko Sawada, Takemi Akahane, Soichiro Saikawa, Keisuke Nakanishi, Takuya Kubo, Masanori Furukawa, Ryuichi Noguchi, Kiyoshi Asada, Koh Kitagawa, Takahiro Ozutsumi, Yuki Tsuji, Daisuke Kaya, Yukihisa Fujinaga, Hitoshi Yoshiji. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis. Hepatology Communications 2017; 1(9): 928 doi: 10.1002/hep4.1104
|
| 13 |
Lei Zheng, Chen Sun, Xingyi Zhu, Wenhao Xu, Jingbo Yu, Qihong Zhang, Alexandr V. Dushkin, Weike Su. Inositol hexanicotinate self-micelle solid dispersion is an efficient drug delivery system in the mouse model of non-alcoholic fatty liver disease. International Journal of Pharmaceutics 2021; 602: 120576 doi: 10.1016/j.ijpharm.2021.120576
|
| 14 |
Jing-ping Zhou, Yan-dan Ren, Qin-yu Xu, Yang Song, Fei Zhou, Mei-Ya Chen, Jing-jing Liu, Li-Gang Chen, Jin-Shui Pan. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4087928
|
| 15 |
Sami Gharbia, Simona-Rebeca Nazarie, Sorina Dinescu, Cornel Balta, Hildegard Herman, Victor Eduard Peteu, Mihaela Gherghiceanu, Anca Hermenean, Marieta Costache. Adipose-Derived Stem Cells (ADSCs) Supplemented with Hepatocyte Growth Factor (HGF) Attenuate Hepatic Stellate Cell Activation and Liver Fibrosis by Inhibiting the TGF-β/Smad Signaling Pathway in Chemical-Induced Liver Fibrosis Associated with Diabetes. Cells 2022; 11(21): 3338 doi: 10.3390/cells11213338
|
| 16 |
Xue-Kai Wang, Zong-Gen Peng. Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655557
|
| 17 |
Michał Kukla. Angiogenesis: a phenomenon which aggravates chronic liver disease progression. Hepatology International 2013; 7(1): 4 doi: 10.1007/s12072-012-9391-2
|
| 18 |
|
| 19 |
Gülsüm Özlem Elpek. Angiogenesis and liver fibrosis. World Journal of Hepatology 2015; 7(3): 377-391 doi: 10.4254/wjh.v7.i3.377
|
| 20 |
Stephanie Coulon, Femke Heindryckx, Anja Geerts, Christophe Van Steenkiste, Isabelle Colle, Hans Van Vlierberghe. Angiogenesis in chronic liver disease and its complications. Liver International 2011; 31(2): 146 doi: 10.1111/j.1478-3231.2010.02369.x
|
| 21 |
Vahid Pouresmaeil, Shaker Ebre, Mohammad Sarafraz Yazdi. Assessment of the Relationship Between CD34 Antigen and Vitamin D Level and Insulin Resistance in Patients With Type 2 Diabetes. Clinical Diabetes 2022; 40(4): 425 doi: 10.2337/cd21-0091
|
| 22 |
Eric R. Kallwitz. Hepatic fibrosis developing in morbid obesity independent of steatohepatitis: new mechanism or the Rube Goldberg machine?. Hepatology International 2013; 7(1): 1 doi: 10.1007/s12072-012-9358-3
|
| 23 |
Roberta Bartucci, Anna Salvati, Peter Olinga, Ykelien L. Boersma. Vanin 1: Its Physiological Function and Role in Diseases. International Journal of Molecular Sciences 2019; 20(16): 3891 doi: 10.3390/ijms20163891
|
| 24 |
Adel Hammoutene, Pierre-Emmanuel Rautou. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. Journal of Hepatology 2019; 70(6): 1278 doi: 10.1016/j.jhep.2019.02.012
|
| 25 |
Yoshio Sumida, Yuichiro Eguchi, Masafumi Ono. Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. World Journal of Hepatology 2010; 2(10): 374-383 doi: 10.4254/wjh.v2.i10.374
|
| 26 |
Kosuke Kaji, Hitoshi Yoshiji, Mitsuteru Kitade, Yasuhide Ikenaka, Ryuichi Noguchi, Yusaku Shirai, Yosuke Aihara, Tadashi Namisaki, Junichi Yoshii, Koji Yanase, Tatsuhiro Tsujimoto, Hideto Kawaratani, Hiroshi Fukui. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 300(6): G1094 doi: 10.1152/ajpgi.00365.2010
|
| 27 |
Pradipta Mukherjee, Shinichi Fukuda, Donny Lukmanto, Toshiharu Yamashita, Kosuke Okada, Shuichi Makita, Ibrahim Abd El-Sadek, Arata Miyazawa, Lida Zhu, Rion Morishita, Antonia Lichtenegger, Tetsuro Oshika, Yoshiaki Yasuno. Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography. Biomedical Optics Express 2022; 13(7): 4071 doi: 10.1364/BOE.461433
|
| 28 |
Jieun Moon, Eunji Kong, Jingu Lee, Jinjoo Jung, Eunha Kim, Seung Bum Park, Pilhan Kim. Intravital longitudinal imaging of hepatic lipid droplet accumulation in a murine model for nonalcoholic fatty liver disease. Biomedical Optics Express 2020; 11(9): 5132 doi: 10.1364/BOE.395890
|
| 29 |
S Lefere, F Van de Velde, L Devisscher, M Bekaert, S Raevens, X Verhelst, Y Van Nieuwenhove, M Praet, A Hoorens, C Van Steenkiste, H Van Vlierberghe, B Lapauw, A Geerts. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. International Journal of Obesity 2017; 41(8): 1207 doi: 10.1038/ijo.2017.102
|
| 30 |
Sander Lefere, Frederique Van de Velde, Anne Hoorens, Sarah Raevens, Sanne Van Campenhout, Astrid Vandierendonck, Sara Neyt, Bert Vandeghinste, Christian Vanhove, Charlotte Debbaut, Xavier Verhelst, Jo Van Dorpe, Christophe Van Steenkiste, Christophe Casteleyn, Bruno Lapauw, Hans Van Vlierberghe, Anja Geerts, Lindsey Devisscher. Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease. Hepatology 2019; 69(3): 1087 doi: 10.1002/hep.30294
|
| 31 |
Alex L. Wilkinson, Maria Qurashi, Shishir Shetty. The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00990
|
| 32 |
A A Shipovskaya, O P Dudanova, I V Kurbatova. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2018; 90(8): 63 doi: 10.26442/terarkh201890863-68
|
| 33 |
Davide Povero, Akiko Eguchi, Ingrid R. Niesman, Nektaria Andronikou, Xavier de Mollerat du Jeu, Anny Mulya, Michael Berk, Milos Lazic, Samjana Thapaliya, Maurizio Parola, Hemal H. Patel, Ariel E. Feldstein. Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells. Science Signaling 2013; 6(296) doi: 10.1126/scisignal.2004512
|